MACPAC Votes To Recommend Congress Let States Restrict Drug Coverage

By Gabrielle Wanneh / January 27, 2023 at 5:04 PM
The Medicaid and CHIP Payment and Access Commission (MACPAC) on Friday (Jan. 27) voted to recommend Congress grant states the ability to impose Medicaid coverage limitations on drugs approved by FDA that lack full evidence of efficacy and for which CMS restricts Medicare coverage as more evidence is gathered on whether the drugs work. This would let states impose the same restrictions imposed by Medicare for outpatient drugs that fall under national coverage determinations (NCDs) with coverage with evidence development...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.